专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US07110859B2 Setting method and setting apparatus for operation path for articulated robot 有权
标题翻译：铰接式机器人操作路径的设置方法和设定装置
公开(公告)号：US07110859B2
公开(公告)日：2006-09-19
申请号：US10468365
申请日：2001-11-22
申请人： Kaoru Shibata , Ryo Nakajima , Masakatsu Kaneko
发明人： Kaoru Shibata , Ryo Nakajima , Masakatsu Kaneko
IPC分类号： G06F19/00
CPC分类号： B25J9/1666 , B23K11/11 , G05B2219/39094 , G05B2219/45104
摘要： A temporary operation path is set by connecting a plurality of welding points in a virtual space generated by a computer to investigate whether an end effector can be operated along the temporary operation path. If the operation cannot be operated, a path to avoid interference with a workpiece is set automatically while extracting a portion in which the workpiece exists in the internal space surrounded by the end effector in order to set a narrow-area operation path for withdrawing the end effector from a welding point. Next, in order to set a wide-area operation path for making movement between withdrawing points, a template operation is applied, in which the end effector is moved by a prescribed distance in a prescribed direction.
摘要翻译：通过将由计算机生成的虚拟空间中的多个焊接点连接起来来调查末端执行器是否可以沿着临时操作路径操作来设置临时操作路径。如果无法操作操作，则自动设置避免工件干涉的路径，同时在由端部执行器包围的内部空间中提取工件的部分提取部分，以便设置用于取出端部的窄区域操作路径效应器从焊接点。接下来，为了设定用于在抽出点之间移动的广域操作路径，应用模板操作，其中端部执行器沿规定方向移动规定距离。

2. 发明授权

US5807837A Composition and method for the treatment or prophylaxis of viral infections using modified oligodeoxyribonucleotides 失效
标题翻译：用修饰的寡脱氧核糖核苷酸治疗或预防病毒感染的组合物和方法
公开(公告)号：US5807837A
公开(公告)日：1998-09-15
申请号：US457151
申请日：1995-06-01
申请人： Hidehiko Furukawa , Kenji Momota , Hitoshi Hotoda , Makoto Koizumi , Masakatsu Kaneko
发明人： Hidehiko Furukawa , Kenji Momota , Hitoshi Hotoda , Makoto Koizumi , Masakatsu Kaneko
IPC分类号： C07H21/02 , A61K31/695 , A61K31/70 , A61K31/711 , A61P31/12 , C07C317/00 , C07C317/50 , C07C323/00 , C07C323/52 , C07H21/00 , C07H21/04 , C08B37/00 , C08F12/00 , C08F20/00 , C08G65/00 , C12N5/06
CPC分类号： C07H21/00 , C07H21/04
摘要： A composition and method of treatment or prophylaxis of a viral infection in a mammal, such as a human, are provided. The compounds in the composition and which are administered in the method, are oligodeoxyribonucleic acid derivatives of the formula (1): ##STR1## wherein R.sub.1, R.sub.2 and R.sub.3 are hydrogen atoms, alkyl groups, aryl groups, and anthraquinonyl groups; Z is carbon or silicon; or R.sub.2, R.sub.3 and Z together represent fluorenyl or xanthenyl; R.sub.4 is a hydrogen atom, an alkyl group or an aryl group; Y.sub.1, Y.sub.3 and Y.sub.4 are oxygen, sulfur or >NH; Y.sub.2 is oxygen, sulfur, >NH, alkylene or phenylene; X is an alkylene group; m and n are each 0 to 10; and B is an oligodeoxyribonucleotide of a chain length of 3 to 9, or salts thereof.
摘要翻译：提供了治疗或预防哺乳动物（例如人）中的病毒感染的组合物和方法。该组合物中的化合物在该方法中给予，是式（1）的寡脱氧核糖核酸衍生物：其中R1，R2和R3是氢原子，烷基，芳基和蒽醌基; Z是碳或硅; 或R 2，R 3和Z一起表示芴基或呫吨; R4是氢原子，烷基或芳基; Y1，Y3和Y4是氧，硫或> NH; Y2是氧，硫，> NH，亚烷基或亚苯基; X是亚烷基; m和n各自为0至10; 且B为链长为3至9的寡脱氧核糖核苷酸，或其盐。

3. 发明授权

US5616600A Griseolic acid compounds and their use as a phosphodiesterase inhibitor 失效
标题翻译：绿藻酸化合物及其作为磷酸二酯酶抑制剂的用途
公开(公告)号：US5616600A
公开(公告)日：1997-04-01
申请号：US437644
申请日：1995-05-09
申请人： Masakatsu Kaneko , Yoshinobu Murofushi , Misako Kimura , Mitsuo Yamazaki , Yasuteru Iijima
发明人： Masakatsu Kaneko , Yoshinobu Murofushi , Misako Kimura , Mitsuo Yamazaki , Yasuteru Iijima
IPC分类号： C07D233/54 , C07H19/02 , A61K31/415 , C07D233/02 , C07D233/04
CPC分类号： C07H19/02 , Y02P20/55
摘要： A compound of the formula (I) is provided ##STR1## wherein A represents a group of the formula: ##STR2## R.sup.1 and R.sup.2 are independently hydrogen, halogen or a group of the formula --OR.sup.9 ; R.sup.9 is hydrogen, alkyl, alkylsulfonyl, haloalkylsulfonyl, arylsulfonyl or a hydroxy-protecting group; R.sup.3 and R.sup.4 are independently carbamoyl or carboxy; R.sup.5 and R.sup.6 both represent hydrogen or together represent an extra carbon-carbon bond between the carbon atoms to which they are attached; and Z represents hydrogen or unsubstituted or substituted hydroxy; or a pharmaceutically acceptable salt or ester thereof. The compounds are useful as inhibitors of phosphodiesterases.
摘要翻译：提供式（I）的化合物，其中A表示下式的基团：R 1和R 2独立地是氢，卤素或式-OR 9的基团; R9是氢，烷基，烷基磺酰基，卤代烷基磺酰基，芳基磺酰基或羟基保护基团; R3和R4独立地是氨基甲酰基或羧基; R5和R6都表示氢或一起代表它们所连接的碳原子之间的额外碳 - 碳键; Z表示氢或未取代或取代的羟基; 或其药学上可接受的盐或酯。这些化合物可用作磷酸二酯酶的抑制剂。

4. 发明授权

US5556975A Griseolic acid derivatives 失效
标题翻译：灰黄酸衍生物
公开(公告)号：US5556975A
公开(公告)日：1996-09-17
申请号：US437634
申请日：1995-05-09
申请人： Masakatsu Kaneko , Yoshinobu Murofushi , Misako Kimura , Mitsuo Yamazaki , Yasuteru Iijima
发明人： Masakatsu Kaneko , Yoshinobu Murofushi , Misako Kimura , Mitsuo Yamazaki , Yasuteru Iijima
IPC分类号： C07D233/54 , C07H19/02 , C07D473/34 , A61K31/52
CPC分类号： C07H19/02 , Y02P20/55
摘要： A compound of the formula (I) is provided ##STR1## wherein A represents a group of the formula: ##STR2## R.sup.1 and R.sup.2 are independently hydrogen, halogen or a group of the formula --OR.sup.9 ; R.sup.3 and R.sup.4 are independently carbamoyl or carboxy; R.sup.5 and R.sup.a both represent hydrogen or together represent an extra carbon-carbon bond between the carbon atoms to which they are attached; and R.sup.9 is hydrogen, alkyl, alkysulfonyl, haloalkylsulfonyl, arylsulfonyl or a hydroxy-protecting group; or a pharmaceutically acceptable salt or ester thereof. The compounds are useful as inhibitors of phosphodiesterases.
摘要翻译：提供式（I）的化合物，其中A表示下式的基团：R 1和R 2独立地是氢，卤素或式-OR 9的基团; R3和R4独立地是氨基甲酰基或羧基; R5和Ra都表示氢或一起代表它们所连接的碳原子之间的额外碳 - 碳键; 且R 9为氢，烷基，烷磺酰基，卤代烷基磺酰基，芳基磺酰基或羟基保护基团; 或其药学上可接受的盐或酯。这些化合物可用作磷酸二酯酶的抑制剂。

5. 发明授权

US5391564A Rhizoxin derivatives and their use as anti-tumor agents 失效
标题翻译：根瘤菌素衍生物及其作为抗肿瘤剂的用途
公开(公告)号：US5391564A
公开(公告)日：1995-02-21
申请号：US195574
申请日：1994-02-14
申请人： Masakatsu Kaneko , Makoto Kamokari , Tomowo Kobayashi , Kazuhiko Sasagawa
发明人： Masakatsu Kaneko , Makoto Kamokari , Tomowo Kobayashi , Kazuhiko Sasagawa
IPC分类号： C07D493/22 , A61K31/365 , A61K31/675 , A61P35/00 , C07D493/18 , C07F9/6561
CPC分类号： C07D493/18 , Y02P20/55
摘要： Rhizoxin and rhizoxin-2-ene derivatives of formula (I): ##STR1## in which: n is 1 to 25: A is an extra bond or oxygen, X is oxygen, sulfur, nitrogen or carbonyl; and R is hydrogen, carboxylic acyl having from 1 to 25 carbon atoms, alkoxycarbonyl group having from 2 to 26 carbon atoms, phosphono, alkylphosphono group in which the alkyl part has from 1 to 25 carbon atoms, dialkylphosphono group in which each alkyl part has from 1 to 25 carbon atoms, alkyl group having from 1 to 25 carbon atoms, aralkyl, cycloalkyl, heterocyclic, alkylthio group in which the alkyl part has from 1 to 25 carbon atoms, aralkylthio, or heterocyclylthio, or when X represents a nitrogen atom, R is R.sup.1 and R.sup.2, where R.sup.1 and R.sup.2 are hydrogen, alkyl, acyl, alkoxycarbonyl, phosphono, alkylphosphono or dialkylphosphono have valuable anti-tumor activity. They may be prepared by acylation of rhizoxin or rhizoxin-2-ene.
摘要翻译：（I）的根瘤菌素和根瘤素-2-烯衍生物：其中：n为1至25：A为额外键或氧，X为氧，硫，氮或羰基; R为氢，具有1至25个碳原子的羧酰基，具有2至26个碳原子的烷氧基羰基，膦酰基，烷基部分为1至25个碳原子的烷基膦酰基，其中每个烷基部分具有的二烷基膦酰基 1至25个碳原子，具有1至25个碳原子的烷基，其中烷基部分具有1至25个碳原子的芳烷基，环烷基，杂环，烷硫基，芳烷硫基或杂环硫基，或当X表示氮原子时 R为R 1和R 2，其中R 1和R 2为氢，烷基，酰基，烷氧基羰基，膦酰基，烷基膦酰基或二烷基膦酰基具有有价值的抗肿瘤活性。它们可以通过根瘤菌素或根瘤素-2-烯的酰化来制备。

6. 发明授权

US4634706A Griseolic acid derivatives, and their use as enzyme inhibitors 失效
标题翻译：绿藻酸衍生物及其作为酶抑制剂的用途
公开(公告)号：US4634706A
公开(公告)日：1987-01-06
申请号：US664866
申请日：1984-10-25
申请人： Masakatsu Kaneko , Misako Kimura , Yoshinobu Murofushi , Mitsuo Yamazaki , Nobuyoshi Iwata , Fumio Nakagawa
发明人： Masakatsu Kaneko , Misako Kimura , Yoshinobu Murofushi , Mitsuo Yamazaki , Nobuyoshi Iwata , Fumio Nakagawa
IPC分类号： C07H19/16 , A61K31/70 , A61K31/7042 , A61K31/7052 , A61K31/7076 , A61K31/708 , A61P5/12 , A61P7/02 , A61P25/28 , A61P35/00 , A61P43/00 , C07D307/77 , C07D405/06 , C07D473/00 , C07D473/30 , C07D493/04 , C07H19/02 , A61K31/52 , C07D473/34 , C07D473/38 , C07D473/40
CPC分类号： C07H19/02
摘要： Griseolic acid derivatives of formula (I): ##STR1## wherein A represents: ##STR2## have enzyme-inhibitory activity, especially against cAMP PDE and cGMP PDE. When formulated as compositions with appropriate carriers or diluents, they may be used for the treatment of a variety of organic disorders and show toxicities less than griseolic acid itself.
摘要翻译：式（I）的格列酚酸衍生物：其中A表示：具有酶抑制活性，特别是针对cAMP PDE和cGMP PDE。当配制成具有适当载体或稀释剂的组合物时，它们可用于治疗各种有机疾病，并且显示低于griseolic acid本身的毒性。

7. 发明申请

US20110009471A1 Oligonucleotide analogues and methods utilizing the same 有权
标题翻译：寡核苷酸类似物和利用其的方法
公开(公告)号：US20110009471A1
公开(公告)日：2011-01-13
申请号：US12804500
申请日：2010-07-22
申请人： Masakatsu Kaneko , Koji Morita , Takeshi Imanishi
发明人： Masakatsu Kaneko , Koji Morita , Takeshi Imanishi
IPC分类号： A61K31/7088 , A61K31/7084 , A61P29/00 , A61P17/06 , A61P31/18 , A61P31/22 , A61P31/16 , A61P35/00 , C07H21/04 , C12P19/34 , G01N33/50
CPC分类号： C07H19/10 , C07H19/06 , C07H19/16 , C07H19/20 , Y02P20/55 , Y10T436/143333
摘要： A method for the prevention or treatment in a mammal of a disease preventable or treatable by the pharmacologically useful antisense or antigene activity of an oligonucleotide analogue or a pharmacologically acceptable salt thereof in the body of said mammal, which method comprises administering to said mammal in need of such prevention or treatment a pharmaceutically effective amount of an oligonucleotide analogue comprising two or more nucleoside units, wherein at least one of said nucleoside units is a structure of the formula (2): wherein A is methylene; and B is an unsubstituted purin-9-yl, an unsubstituted 2-oxo-pyrimidin-1-yl or a substituted purin-9-yl; or a pharmacologically acceptable salt thereof.
摘要翻译：一种用于预防或治疗哺乳动物的疾病，其可通过所述哺乳动物体内的寡核苷酸类似物或其药理学上可接受的盐的药理学上有用的反义或反应活性可预防或治疗的疾病，所述方法包括向需要的所述哺乳动物施用这样的预防或治疗药物有效量的包含两个或多个核苷单位的寡核苷酸类似物，其中所述核苷单元中的至少一个是式（2）的结构：其中A是亚甲基; 和B是未取代的嘌呤-9-基，未取代的2-氧代 - 嘧啶-1-基或取代的嘌呤-9-基; 或其药理学上可接受的盐。

8. 发明授权

US07816333B2 Oligonucleotide analogues and methods utilizing the same 有权
标题翻译：寡核苷酸类似物和利用其的方法
公开(公告)号：US07816333B2
公开(公告)日：2010-10-19
申请号：US11881775
申请日：2007-07-27
申请人： Masakatsu Kaneko , Koji Morita , Takeshi Imanishi
发明人： Masakatsu Kaneko , Koji Morita , Takeshi Imanishi
IPC分类号： A01N43/04 , A61K31/70
CPC分类号： C07H19/10 , C07H19/06 , C07H19/16 , C07H19/20 , Y02P20/55 , Y10T436/143333
摘要： A method for the prevention or treatment in a mammal of a disease preventable or treatable by the pharmacologically useful antisense or antigene activity of an oligonucleotide analogue or a pharmacologically acceptable salt thereof in the body of said mammal, which method comprises administering to said mammal in need of such prevention or treatment a pharmaceutically effective amount of an oligonucleotide analogue comprising two or more nucleoside units, wherein at least one of said nucleoside units is a structure of the formula (2): wherein A is methylene; and B is an unsubstituted purin-9-yl, an unsubstituted 2-oxo-pyrimidin-1-yl or a substituted purin-9-yl; or a pharmacologically acceptable salt thereof.
摘要翻译：一种用于预防或治疗哺乳动物的疾病，其可通过所述哺乳动物体内的寡核苷酸类似物或其药理学上可接受的盐的药理学上有用的反义或反应活性可预防或治疗的疾病，所述方法包括向需要的所述哺乳动物施用这样的预防或治疗药物有效量的包含两个或多个核苷单位的寡核苷酸类似物，其中所述核苷单元中的至少一个是式（2）的结构：其中A是亚甲基; 和B是未取代的嘌呤-9-基，未取代的2-氧代 - 嘧啶-1-基或取代的嘌呤-9-基; 或其药理学上可接受的盐。

9. 发明申请

US20090149404A1 Oligonucleotide analogues and methods utilizing the same 有权
标题翻译：寡核苷酸类似物和利用其的方法
公开(公告)号：US20090149404A1
公开(公告)日：2009-06-11
申请号：US11881775
申请日：2007-07-27
申请人： Masakatsu Kaneko , Koji Morita , Takeshi Imanishi
发明人： Masakatsu Kaneko , Koji Morita , Takeshi Imanishi
IPC分类号： A61K31/7084 , C12Q1/68 , C07H21/00
CPC分类号： C07H19/10 , C07H19/06 , C07H19/16 , C07H19/20 , Y02P20/55 , Y10T436/143333
摘要： A method for the prevention or treatment in a mammal of a disease preventable or treatable by the pharmacologically useful antisense or antigene activity of an oligonucleotide analogue or a pharmacologically acceptable salt thereof in the body of said mammal, which method comprises administering to said mammal in need of such prevention or treatment a pharmaceutically effective amount of an oligonucleotide analogue comprising two or more nucleoside units, wherein at least one of said nucleoside units is a structure of the formula (2): wherein A is methylene; and B is an unsubstituted purin-9-yl, an unsubstituted 2-oxo-pyrimidin-1-yl or a substituted purin-9-yl; or a pharmacologically acceptable salt thereof.
摘要翻译：一种用于预防或治疗哺乳动物的疾病，其可通过所述哺乳动物体内的寡核苷酸类似物或其药理学上可接受的盐的药理学上有用的反义或反应活性可预防或治疗的疾病，所述方法包括向需要的所述哺乳动物施用这样的预防或治疗药物有效量的包含两个或多个核苷单位的寡核苷酸类似物，其中所述核苷单元中的至少一个是式（2）的结构：其中A是亚甲基; 和B是未取代的嘌呤-9-基，未取代的2-氧代 - 嘧啶-1-基或取代的嘌呤-9-基; 或其药理学上可接受的盐。

10. 发明申请

US20090066930A1 MEASUREMENT SYSTEM 失效
标题翻译：测量系统
公开(公告)号：US20090066930A1
公开(公告)日：2009-03-12
申请号：US12207105
申请日：2008-09-09
申请人： Masakatsu Kaneko , Sze Yun Set , Chee Seong Goh , Morisato Namikawa , Yuichi Nagashima , Tomoharu Kotake , Hiroshi Yaguchi
发明人： Masakatsu Kaneko , Sze Yun Set , Chee Seong Goh , Morisato Namikawa , Yuichi Nagashima , Tomoharu Kotake , Hiroshi Yaguchi
IPC分类号： G01C3/08
CPC分类号： G01S7/4812 , G01B11/026 , G01S17/08
摘要： A measurement system 1 for measuring a distance to an object to be measured, includes: a half mirror 10; a measurement light emitting unit 11; a projection unit 12; a light-receiving unit 13; a distance calculation unit 14; and a diffusion lens 16.
摘要翻译：用于测量与待测物体的距离的测量系统1包括：半透半反镜10; 测量发光单元11; 投影单元12; 光接收单元13; 距离计算单元14; 和漫射透镜16。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式